These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35429946)

  • 21. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of nCPAP for moderate preterm infants compared to BiPAP: A Randomized, Controlled Non-Inferiority Trial.
    Lee MJ; Choi EK; Park KH; Shin J; Choi BM
    Pediatr Int; 2020 Jan; 62(1):59-64. PubMed ID: 31765030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humidified High Flow Nasal Cannula versus Nasal Continuous Positive Airway Pressure as an Initial Respiratory Support in Preterm Infants with Respiratory Distress: a Randomized, Controlled Non-Inferiority Trial.
    Shin J; Park K; Lee EH; Choi BM
    J Korean Med Sci; 2017 Apr; 32(4):650-655. PubMed ID: 28244292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden versus gradual pressure wean from Nasal CPAP in preterm infants: a randomized controlled trial.
    Amatya S; Macomber M; Bhutada A; Rastogi D; Rastogi S
    J Perinatol; 2017 Jun; 37(6):662-667. PubMed ID: 28230835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.
    Nakhshab M; Tajbakhsh M; Khani S; Farhadi R
    Pediatr Neonatol; 2015 Apr; 56(2):88-94. PubMed ID: 25264154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binasal Prong versus Nasal Mask for Applying CPAP to Preterm Infants: A Randomized Controlled Trial.
    Say B; Kanmaz Kutman HG; Oguz SS; Oncel MY; Arayici S; Canpolat FE; Uras N; Karahan S
    Neonatology; 2016; 109(4):258-64. PubMed ID: 26859512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; De Paoli AG
    Cochrane Database Syst Rev; 2000; (3):CD002272. PubMed ID: 10908544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial].
    Yao LS; Lin XZ; Huang J; Tang LX
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Jan; 23(1):31-36. PubMed ID: 33476534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; de Paoli AG
    Cochrane Database Syst Rev; 2002; (1):CD002272. PubMed ID: 11869635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal continuous positive airway pressure (NCPAP) or noninvasive neurally adjusted ventilatory assist (NIV-NAVA) for preterm infants with respiratory distress after birth: A randomized controlled trial.
    Yagui AC; Meneses J; Zólio BA; Brito GMG; da Silva RJ; Rebello CM
    Pediatr Pulmonol; 2019 Nov; 54(11):1704-1711. PubMed ID: 31393072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized, controlled study of NIPPV versus nCPAP in preterm and term infants with respiratory distress syndrome.
    Shi Y; Tang S; Zhao J; Shen J
    Pediatr Pulmonol; 2014 Jul; 49(7):673-8. PubMed ID: 24039148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure for preterm infants with respiratory distress syndrome: a meta-analysis and up-date.
    Li W; Long C; Zhangxue H; Jinning Z; Shifang T; Juan M; Renjun L; Yuan S
    Pediatr Pulmonol; 2015 Apr; 50(4):402-9. PubMed ID: 25418007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of early caffeine treatment on the need for respirator therapy in preterm infants with respiratory distress syndrome].
    Wei QZ; Su P; Han JT; Zhang X; Duan YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1227-1231. PubMed ID: 27974112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates.
    Finer NN; Merritt TA; Bernstein G; Job L; Mazela J; Segal R
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):303-9. PubMed ID: 20455772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of non-synchronized Nasopharyngeal Intermittent Mandatory Ventilation (nsNIMV) vs. Nasal Continuous Positive Airway Pressure (NCPAP) in the prevention of extubation failure in pre-term < 1,500 grams.
    Khorana M; Paradeevisut H; Sangtawesin V; Kanjanapatanakul W; Chotigeat U; Ayutthaya JK
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S136-42. PubMed ID: 19253509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the efficacy of Seattle-PAP for the respiratory support of premature neonates: study protocol for a randomized controlled trial.
    Backes CH; Notestine JL; Lamp JM; Balough JC; Notestine AM; Alfred CM; Kern JM; Stenger MR; Rivera BK; Moallem M; Miller RR; Naik A; Cooper JN; Howard CR; Welty SE; Hillman NH; Zupancic JAF; Stanberry LI; Hansen TN; Smith CV
    Trials; 2019 Jan; 20(1):63. PubMed ID: 30658678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.